Frank Dolan Founder of ARSENAL ADVISORS
Linkedin
Contact

Frank F. Dolan

Founder

Frank has spent over twenty years in biopharmaceuticals serving in commercial leadership roles. At Takeda, Amylin, and Acadia Pharmaceuticals he was a founding member of the team that brought them from R&D-only into launch-ready commercial organizations. His 15 product launches include large market brands such as Lipitor to orphan drug portfolios. 

Frank’s strong record of increasing company value has resulted in company acquisitions of over $100 billion.

2019 & 2020: LinkedIn ranked Top 1% in Biotech

Past Employers

Diverse Commercial Leadership Experience

Award Winning Brands

History of Brand Impact Recognized by Industry Associations & Press
Previous
Next

Contact Us

How May We Help You

Thank you for your interest

ARSENAL ADVISORS is committed to protecting your information. Your information will be used in accordance with the applicable data privacy law, our internal policies and our Privacy Policy. As ARSENAL ADVISORS is a global organization, your information may be stored and processed by ARSENAL ADVISORS and its affiliates in countries outside your country of residence, but wherever your information is processed, we will handle it with the same care and respect for your privacy.

We use cookies essential for this site to function well. Please click “Accept” to help us improve its usefulness with additional cookies. Learn about our use of cookies, and collaboration with select social media and trusted analytics partners in our Terms of Use.​

ACCEPT AND CLOSE
DECLINE